Finance

Lists
Why is 603883 up 4.95%?
Dive Deeper
603883:SHA
LBX Pharmacy Chain JSC
CN¥14.20
+4.95%
(+0.67) 1D
Oct 12, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603883...
Open
CN¥13.53
High
CN¥14.30
Low
CN¥13.52
Mkt. cap
10.27B
Avg. vol.
10.94M
Volume
29.49M
Dividend
4.34%
Quarterly dividend
CN¥0.15
Ex-dividend date
Sep 10, 2026
P/E ratio
24.83
52-wk high
CN¥17.96
52-wk low
CN¥10.67
EPS
CN¥0.57
Shares outstanding
284.95M
No. of employees
37K
Open
CN¥13.53
High
CN¥14.30
Low
CN¥13.52
Mkt. cap
10.27B
Avg. vol.
10.94M
Volume
29.49M
Dividend
4.34%
Quarterly dividend
CN¥0.15
Ex-dividend date
Sep 10, 2026
P/E ratio
24.83
52-wk high
CN¥17.96
52-wk low
CN¥10.67
EPS
CN¥0.57
Shares outstanding
284.95M
No. of employees
37K
News stories
From web sources and news partners
About LBX Pharmacy Chain JSC
CEO-
Employees36.9K
Founded2001
Headquarters-
SectorDrug
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.30B
6.17B
5.48B
5.52B
Cost of goods sold
3.63B
4.22B
3.64B
3.79B
Cost of revenue
3.63B
4.22B
3.64B
3.79B
Research and development expenses
26.78M
-12.60M
12.09M
11.83M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.43B
1.70B
1.41B
1.37B
Operating expense
1.47B
1.70B
1.42B
1.41B
Total operating expenses
5.10B
5.92B
5.07B
5.20B
Operating income
198.10M
244.44M
414.00M
319.79M
Other non operating income
6.77M
-17.43M
-
-3.98M
EBT including unusual items
189.03M
-37.11M
385.81M
310.55M
EBT excluding unusual items
169.98M
206.00M
386.99M
294.15M
Income tax expense
28.62M
58.81M
83.45M
89.03M
Effective tax rate
15.14%
-158.50%
21.63%
28.67%
Other operating expenses
10.63M
-7.90M
5.33M
22.79M
Net income
130.78M
-146.80M
263.86M
182.93M
Net profit margin
2.47%
-2.38%
4.81%
3.32%
Earnings per share
-
-
-
-
Interest and investment income
-
10.08M
980.03K
9.40M
Interest expense
-34.89M
-31.09M
-27.98M
-31.06M
Net interest expenses
-34.89M
-21.01M
-27.00M
-21.66M
Depreciation and amortization charges
-
-
-
-
EBITDA
243.06M
287.44M
-
357.89M
Gain or loss from assets sale
294.70K
3.54M
-
1.24M
AI content may include mistakes. Learn more
Google apps